The pathophysiology of chronic graft failure in the cardiac transplant patient

U A Khan1, S G Williams, J E Fildes

  • 1North West Regional Heart Centre and Transplant Unit, University of South Manchester NHS Foundation Trust, Wythenshawe Hospital, Manchester, UK.

Insights

Chronic cardiac graft failure (CGF) after heart transplant resembles chronic heart failure (CHF) but involves unique mechanisms. Understanding CGF pathophysiology is crucial for transplant medicine.

Area of Science:

  • Cardiology
  • Transplant Medicine
  • Pathophysiology

Background:

  • Cardiac transplantation can lead to chronic graft failure (CGF).
  • CGF clinically resembles native chronic heart failure (CHF).
  • Shared and unique pathophysiological mechanisms contribute to CGF.

Purpose of the Study:

  • To review the complex pathophysiology of chronic cardiac graft failure (CGF) post-transplantation.
  • To highlight CGF as a significant but under-recognized condition in transplant medicine.

Main Methods:

  • Literature review of studies on cardiac graft function and failure.
  • Analysis of pathophysiological processes in chronic cardiac graft failure.
  • Comparison of CGF mechanisms with those of native chronic heart failure.

Main Results:

  • CGF involves pathophysiological processes similar to CHF.
  • The post-transplant environment introduces unique mechanisms contributing to CGF.
  • These unique mechanisms warrant specific attention in CGF research.

Conclusions:

  • Chronic cardiac graft failure is a complex condition with both shared and unique pathophysiological drivers.
  • Further research into the specific mechanisms of CGF is essential for improving long-term transplant outcomes.

Related Concept Videos

Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
Tissue Transplantation01:24

Tissue Transplantation

Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
Cell-mediated Immune Responses01:40

Cell-mediated Immune Responses

Overview
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...